Jackson Wealth Management LLC acquired a new stake in Clorox Company (The) (NYSE:CLX) in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 10,068 shares of the company’s stock, valued at approximately $1,340,000.

Several other hedge funds have also made changes to their positions in the stock. Vanguard Group Inc. grew its holdings in shares of Clorox Company (The) by 4.8% in the first quarter. Vanguard Group Inc. now owns 14,164,716 shares of the company’s stock valued at $1,909,829,000 after purchasing an additional 649,766 shares in the last quarter. BlackRock Inc. grew its holdings in shares of Clorox Company (The) by 1,402.2% in the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock valued at $1,400,912,000 after purchasing an additional 9,698,542 shares in the last quarter. State Street Corp grew its holdings in shares of Clorox Company (The) by 2.2% in the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock valued at $1,031,304,000 after purchasing an additional 167,689 shares in the last quarter. Wells Fargo & Company MN grew its holdings in shares of Clorox Company (The) by 5.3% in the second quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock valued at $587,934,000 after purchasing an additional 221,168 shares in the last quarter. Finally, Parnassus Investments CA acquired a new position in shares of Clorox Company (The) in the first quarter valued at approximately $434,255,000. Hedge funds and other institutional investors own 71.28% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “10,068 Shares in Clorox Company (The) (CLX) Purchased by Jackson Wealth Management LLC” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this article on another website, it was illegally stolen and republished in violation of U.S. & international copyright legislation. The legal version of this article can be accessed at https://www.thecerbatgem.com/2017/09/09/10068-shares-in-clorox-company-the-clx-purchased-by-jackson-wealth-management-llc.html.

In other news, EVP James E. Foster sold 9,861 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the completion of the transaction, the executive vice president now directly owns 22,069 shares in the company, valued at approximately $3,056,777.19. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, SVP Jon M. Balousek sold 9,223 shares of the stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total value of $1,280,798.01. Following the transaction, the senior vice president now owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 21,242 shares of company stock valued at $2,944,449. Company insiders own 0.74% of the company’s stock.

Shares of Clorox Company (NYSE CLX) traded down 1.46% during mid-day trading on Friday, hitting $134.04. 847,109 shares of the stock traded hands. The stock has a market cap of $17.30 billion, a PE ratio of 25.12 and a beta of 0.40. The stock has a 50-day moving average of $135.59 and a 200 day moving average of $135.27. Clorox Company has a one year low of $111.24 and a one year high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. The company had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s revenue was up 2.9% on a year-over-year basis. During the same period in the prior year, the business posted $1.30 EPS. Equities analysts predict that Clorox Company will post $5.66 EPS for the current fiscal year.

CLX has been the subject of a number of research reports. BidaskClub cut shares of Clorox Company (The) from a “hold” rating to a “sell” rating in a report on Wednesday, July 5th. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 price target for the company in a research note on Tuesday, July 4th. Deutsche Bank AG reiterated a “hold” rating and issued a $137.00 price target (up previously from $126.00) on shares of Clorox Company (The) in a research note on Saturday, July 22nd. BMO Capital Markets set a $150.00 price target on shares of Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. Finally, Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price target (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and three have given a buy rating to the stock. The stock presently has an average rating of “Hold” and an average price target of $129.05.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Stock Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related stocks with our FREE daily email newsletter.